|
DENND4A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65709999999653E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.201700E-04 |
| Normal-vs-Stage2 |
1.409800E-04 |
| Normal-vs-Stage3 |
1.36960000007846E-07 |
| Normal-vs-Stage4 |
2.48979999950549E-07 |
| Stage1-vs-Stage2 |
1.991970E-01 |
| Stage1-vs-Stage3 |
1.122220E-02 |
| Stage1-vs-Stage4 |
3.022100E-03 |
| Stage2-vs-Stage3 |
6.795600E-01 |
| Stage2-vs-Stage4 |
3.282000E-01 |
| Stage3-vs-Stage4 |
4.713400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51505999999024E-05 |
| Normal-vs-AfricanAmerican |
8.689500E-02 |
| Normal-vs-Asian |
1.242620E-04 |
| Caucasian-vs-AfricanAmerican |
2.536000E-01 |
| Caucasian-vs-Asian |
5.035400E-01 |
| AfricanAmerican-vs-Asian |
1.386990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.625890E-04 |
| Normal-vs-Female |
1.22560000004324E-06 |
| Male-vs-Female |
9.979400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.696900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.32140000011994E-07 |
| Normal-vs-Age(61-80Yrs) |
6.03249999953093E-08 |
| Normal-vs-Age(81-100Yrs) |
1.843950E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.249700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.439000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.312600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.572220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.458000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.486200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.044700E-04 |
| Classical-VS-Follicular |
9.236000E-03 |
| Classical-VS-Other |
3.502600E-01 |
| Classical-VS-Normal |
2.984000E-04 |
| Tall-VS-Follicular |
2.227400E-01 |
| Tall-VS-Other |
5.159400E-01 |
| Tall-VS-Normal |
9.96290000498945E-08 |
| Follicular-VS-Other |
9.630000E-01 |
| Follicular-VS-Normal |
2.8022000000405E-06 |
| Other-VS-Normal |
2.712000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21489999949098E-07 |
| Normal-vs-N1 |
9.95240000000175E-05 |
| N0-vs-N1 |
7.318000E-01 |
|
|
